Editorial: Novel biomarkers for anticancer therapy
Ting Wang,
Zhe-Sheng Chen,
Chen Shi,
Chen Shi,
Liang Ouyang,
Hongtao Xiao
Affiliations
Ting Wang
Department of Clinical Research, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
Zhe-Sheng Chen
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, NYC, United States
Chen Shi
Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China
Chen Shi
Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, China
Liang Ouyang
State Key Laboratory of Biotherapy, Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, Chengdu, China
Hongtao Xiao
Department of Pharmacy, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
